02/01/2024 | Press release | Archived content
SAN DIEGO, February 1, 2024 - Meet selectION's management team for an update on selectION's best-in-class ion channel blockers and the status of the clinical work in atopic dermatitis, psoriasis vulgaris and psoriatic arthritis.